Status:
COMPLETED
Effect of Computerized Cognitive Training in Persons With MS
Lead Sponsor:
University of Nebraska
Conditions:
Multiple Sclerosis, Relapsing-Remitting
Eligibility:
All Genders
19-60 years
Phase:
NA
Brief Summary
Multiple sclerosis (MS) affects approximately one million people in the United States and 2.5 million worldwide. Between one million and 1.75 million persons with MS (PwMS) worldwide are estimated to ...
Detailed Description
Kathy Healey, MS Specialist and participating personnel on this study, is one of the MS providers at the Nebraska Medicine MS Clinic. She helped determine the following inclusion/exclusion criteria as...
Eligibility Criteria
Inclusion
- Ages 19-60 inclusive
- Expanded Disability Status Scale (EDSS) score of 2-5.5 inclusive
- Relapsing-Remitting MS according to McDonald Criteria
- 17 or above on the Montreal Cognitive Assessment (MoCA)
- 70 or above on the Test of Premorbid Functioning (TOPF)
- 29 or less on the Beck Depression Inventory (BDI-II)
- Less than 15 on the Generalized Anxiety Disorder (GAD-7)
Exclusion
- Relapse within the last 6 months
- Disease modifying treatment (DMT) change within the last 6 months
- Primary Progressive MS or Secondary Progressive MS according to McDonald Criteria
- No access to computer/internet
- Currently undergoing treatment for cognitive impairment
- Answers a 2 or 3 on the suicidal thoughts question of the BDI-II
- Answers a 1 on the suicidal thoughts question of the BDI-II and then a Columbia Suicide Severity Rating Scale indicates more than low risk
Key Trial Info
Start Date :
June 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 21 2022
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT05345288
Start Date
June 28 2022
End Date
October 21 2022
Last Update
September 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nebraska Medical Center
Omaha, Nebraska, United States, 68198